1.925
price down icon6.10%   -0.125
 
loading

Metagenomi Inc (MGX) 最新ニュース

pulisher
06:42 AM

Metagenomi achieves gene integration breakthrough - Investing.com

06:42 AM
pulisher
06:23 AM

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems - GlobeNewswire

06:23 AM
pulisher
06:21 AM

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances ... - The Bakersfield Californian

06:21 AM
pulisher
06:19 AM

Metagenomi Breakthrough: New CRISPR System Enables Large Gene Integration | MGX Stock News - StockTitan

06:19 AM
pulisher
Mar 12, 2025

Rhumbline Advisers Increases Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

Mar 12, 2025
pulisher
Mar 10, 2025

Metagenomi, Inc. (MGX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire

Mar 10, 2025
pulisher
Mar 07, 2025

Metagenomi CFO Pamela Wapnick sells stock for $3,389 - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Metagenomi CFO Pamela Wapnick sells stock for $3,389 By Investing.com - Investing.com UK

Mar 07, 2025
pulisher
Mar 05, 2025

Metagenomi, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – MGX - ACCESS Newswire

Mar 05, 2025
pulisher
Mar 03, 2025

MGX LAWSUIT ALERT: Levi & Korsinsky Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 03, 2025

Metagenomi, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your RightsMGX - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 02, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 25, 2024 in Metagenomi LawsuitMGX - ACCESS Newswire

Mar 02, 2025
pulisher
Mar 02, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 25, 2024 in Metagenomi, Inc. LawsuitMGX - ACCESS Newswire

Mar 02, 2025
pulisher
Mar 02, 2025

Shareholders that lost money on Metagenomi, Inc.(MGX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire

Mar 02, 2025
pulisher
Mar 01, 2025

Metagenomi, Inc. (MGX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Mar 01, 2025
pulisher
Mar 01, 2025

Metagenomi advances gene editing therapies into 2025 - MSN

Mar 01, 2025
pulisher
Feb 28, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Metagenomi, Inc. (MGX) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Metagenomi, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your RightsMGX - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 27, 2025

Levi & Korsinsky Reminds Metagenomi Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 25, 2024MGX - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 21, 2025

MGX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Metagenomi, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 21, 2025
pulisher
Feb 21, 2025

Metagenomi, Inc. (NASDAQ:MGX) Receives $16.67 Average Price Target from Analysts - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

Metagenomi, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for Details- MGX - ACCESS Newswire

Feb 20, 2025
pulisher
Feb 20, 2025

A look into Metagenomi Inc (MGX)’s deeper side - SETE News

Feb 20, 2025
pulisher
Feb 19, 2025

Metagenomi, Inc. (NASDAQ:MGX) Short Interest Update - MarketBeat

Feb 19, 2025
pulisher
Feb 18, 2025

Levi & Korsinsky Reminds Metagenomi, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 25, 2024MGX - ACCESS Newswire

Feb 18, 2025
pulisher
Feb 18, 2025

Peapod Lane Capital LLC Invests $1.27 Million in Metagenomi, Inc. (NASDAQ:MGX) - MarketBeat

Feb 18, 2025
pulisher
Feb 18, 2025

Metagenomi, Inc. (NASDAQ:MGX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Feb 18, 2025
pulisher
Feb 17, 2025

FINAL MGX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Metagenomi, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Feb 17, 2025
pulisher
Feb 17, 2025

These two noteworthy penny stocks can do wonders! Here's more insights into Alto Ingredients, Metagenomi a - The Economic Times

Feb 17, 2025
pulisher
Feb 17, 2025

Alto Ingredients And 2 Other US Penny Stocks To Watch - Simply Wall St

Feb 17, 2025
pulisher
Feb 15, 2025

SG Americas Securities LLC Invests $43,000 in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

Feb 15, 2025
pulisher
Feb 14, 2025

Lead Plaintiff Appointed to Represent Investors in Metagenomi Class Action - TradingView

Feb 14, 2025
pulisher
Feb 13, 2025

MGX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Metagenomi, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 13, 2025
pulisher
Feb 11, 2025

Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference - GlobeNewswire

Feb 11, 2025
pulisher
Feb 10, 2025

Metagenomi Inc [MGX] Insider Activity: An Update for Investors - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

Quarterly Metrics: Quick and Current Ratios for Metagenomi Inc (MGX) - The Dwinnex

Feb 10, 2025
pulisher
Feb 08, 2025

MGX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Metagenomi, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 08, 2025
pulisher
Feb 05, 2025

Analysts review Metagenomi Inc’s rating - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Is Metagenomi Inc (MGX) worth investing in despite its overvalued state? - US Post News

Feb 05, 2025
pulisher
Feb 03, 2025

MGX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Metagenomi, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 03, 2025
pulisher
Feb 03, 2025

Market Watch Highlights: Metagenomi Inc (MGX) Ends on an Downturn Note at 2.69 - The Dwinnex

Feb 03, 2025
pulisher
Jan 28, 2025

Neutral On Metagenomi's Promising Yet Highly Speculative Gene Editing Potential - Seeking Alpha

Jan 28, 2025
pulisher
Jan 28, 2025

Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer - GlobeNewswire Inc.

Jan 28, 2025
pulisher
Jan 28, 2025

The Market Doesn't Like What It Sees From Metagenomi, Inc.'s (NASDAQ:MGX) Revenues Yet As Shares Tumble 26% - Simply Wall St

Jan 28, 2025
pulisher
Jan 27, 2025

Brokerages Set Metagenomi, Inc. (NASDAQ:MGX) Price Target at $16.67 - MarketBeat

Jan 27, 2025
pulisher
Jan 26, 2025

Investors Who Lost Money With NASDAQ:MGX Shares Should Contact the Shareholders Foundation in Connection With Lawsuit Against Metagenomi, Inc - ACCESS Newswire

Jan 26, 2025
pulisher
Jan 25, 2025

Stargate Project’s healthcare winners: AI-led biotechs and Metagenomi - MSN

Jan 25, 2025
pulisher
Jan 25, 2025

FINAL REMINDER MGX DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Metagenomi, Inc. Investors to Participate in the Class Action Lawsuit! - ACCESS Newswire

Jan 25, 2025
pulisher
Jan 24, 2025

StockWatch: Up-to-$500B AI Venture Sparks Investor Interest, and Questions - Genetic Engineering & Biotechnology News

Jan 24, 2025
pulisher
Jan 24, 2025

Metagenomi, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 25, 2024 to Discuss Your Rights – MGX - ACCESS Newswire

Jan 24, 2025
pulisher
Jan 24, 2025

Metagenomi, Inc. (NASDAQ:MGX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

Jan 24, 2025
pulisher
Jan 24, 2025

Metagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Jan 24, 2025
$36.89
price up icon 5.68%
$306.88
price up icon 0.65%
$32.96
price up icon 1.36%
$20.41
price up icon 1.05%
$102.19
price up icon 1.10%
biotechnology ONC
$247.47
price down icon 0.28%
大文字化:     |  ボリューム (24 時間):